Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma Australia

Documents similaires

• Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
  par: Shirlene Sim, et autres
  Publié: (2026)
• The importance of autologous stem cell transplantation in improving outcomes in newly diagnosed patients with multiple myeloma
  par: Morie A. Gertz
  Publié: (2024)
• Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)
  par: Laurent Garderet, et autres
  Publié: (2024)
• Navegando pelo labirinto do silêncio: artistas feministas no México
  par: Edward J. McCaughan
  Publié: (2003)
• Uncovering the ultra‐frail: A distinct subgroup in non‐transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome
  par: Kazimierz Groen, et autres
  Publié: (2025)